Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Income Tax Expense
-$5.28M
TTM · Period ending: · USD
LCTX Income Tax Expense
Latest reported-$5.28Mperiod ending
Latest reported-$5.28Mperiod ending
LCTX TTM Income Tax ($700.00K → -$5.28M)
TTM income tax expense
High-resolution chart · PNG
LCTX income tax expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Income Tax Expense (USD) |
|---|---|
| -5,280,000 | |
| -5,280,000 | |
| -5,280,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,803,000 | |
| -1,803,000 | |
| -1,262,000 | |
| -1,262,000 | |
| 541,000 | |
| 1,722,000 | |
| 169,000 | |
| 0 | |
| 0 | |
| -2,242,000 | |
| -1,408,000 | |
| -1,239,000 | |
| -1,239,000 | |
| -962,000 | |
| -1,775,000 | |
| -3,023,000 | |
| -7,407,000 | |
| -6,969,000 | |
| -5,978,000 | |
| -4,730,000 | |
| -346,000 | |
| -4,772,000 | |
| 0 | |
| -3,877,000 | |
| 0 | |
| -9,235,000 | |
| -14,007,000 | |
| -10,130,000 | |
| -14,007,000 | |
| -1,121,000 | |
| -2,069,000 | |
| -3,340,000 | |
| -4,516,882 | |
| -5,596,516 | |
| -6,961,209 | |
| -7,203,467 | |
| -7,375,611 | |
| 20,061,426 | |
| 22,374,119 | |
| 23,887,377 | |
| 25,236,403 | |
| 0 | |
| -1,005,859 | |
| -1,709,682 | |
| -2,324,785 | |
| -2,419,493 | |
| -1,901,208 | |
| -1,930,021 | |
| -2,142,869 | |
| -3,114,023 | |
| 1,930,357 | |
| 2,645,508 | |
| 3,459,304 | |
| 4,497,216 | |
| -86,090 | |
| -72,243 | |
| -60,224 | |
| 564,663 | |
| 591,163 | |
| 594,801 | |
| 596,937 | |
| 280,908 | |
| 280,908 | |
| 280,908 | |
| 280,908 | |
| 35,931 | |
| 35,931 | |
| 62,595 | |
| 62,595 | |
| 3,526 | |
| 3,526 | |
| -7,578 | |
| -6,514 | |
| -34,697 | |
| 14,821 | |
| -739 | |
| -1,803 | |
| -49,930 | |
| -99,448 | |
| -96,928 | |
| -16,928 | |
| 249,998 | |
| 511,265 | |
| 574,653 | |
| 666,318 | |
| 687,888 | |
| 395,899 | |
| 324,589 | |
| 146,469 | |
| -32,552 |